Skip to Content


In the US, Iloprost (iloprost systemic) is a member of the drug class agents for pulmonary hypertension and is used to treat Pulmonary Hypertension.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Antiplatelet agent

Prostaglandin analogue

Chemical Name

Pentalenevaleric acid, (E)-(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(E)-(3S,4RS)-3-hydroxy-4-metyl-1-octen-6-ynyl]-ݲ(¹H)δ-

Foreign Names

  • Iloprostum (Latin)
  • Iloprost (German)
  • Iloprost (French)
  • Iloprost (Spanish)

Generic Names

  • Iloprost (OS: USAN, DCF, BAN, JAN)
  • Ciloprost (IS)
  • ZK 36374 (IS: Schering)

Brand Names

  • Ilomedin
    Berlimed S.A., Israel; Schering AG, Hong Kong
  • Ilomedin-20
    Bayer, Turkey
  • Ilomédine
    Bayer Santé, France
  • Ventavis
    Actelion, United States; Bayer, Bosnia & Herzegowina; Bayer, China; Bayer, Ecuador; Bayer, Hungary; Bayer, South Korea; Bayer, Turkey; Bayer de México, Mexico; Bayer Healthcare, Indonesia; Bayer Pharma, Slovenia; Bayer Schering, Lithuania; Bayer Thai Co Ltd, Thailand; Berlimed, Taiwan; Berlimed S.A., Israel; Berlimed S.A., Serbia; Schering, Latvia
  • Arrow Iloprost
    Bayer, New Zealand
  • Endoprost
    Italfarmaco, Italy
  • Ilomedin
    Bayer, Bosnia & Herzegowina; Bayer, Denmark; Bayer, Spain; Bayer, Greece; Bayer, Hong Kong; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Italy; Bayer, New Zealand; Bayer, Sweden; Bayer Austria, Austria; Bayer Health Care, Malaysia; Bayer HealthCare, Finland; Bayer HealthCare, Russian Federation; Bayer Pharma AG, Norway; Bayer Schering, Bulgaria; Bayer Schering, Poland; Bayer Schering, Taiwan; Bayer Thai Co Ltd, Thailand; Bayer Vital, Germany; Bayer-Schering, Romania; Berlimed, Portugal
  • Ilomedine
    Bayer, Netherlands
  • Iloprost Basi
    Basi, Portugal
  • Iloprost Ibigen
    Ibigen, Portugal
  • Iloprost IBISQUS
    Ibisqus, Germany
  • Ventavis
    Bayer, Belgium; Bayer, Chile; Bayer, Colombia; Bayer, Denmark; Bayer, Spain; Bayer, United Kingdom; Bayer, Greece; Bayer, Hong Kong; Bayer, Croatia (Hrvatska); Bayer, Ireland; Bayer, Italy; Bayer, Netherlands; Bayer, New Zealand; Bayer, Portugal; Bayer, Sweden; Bayer, Slovakia; Bayer Health Care, Malaysia; Bayer HealthCare, Finland; Bayer HealthCare, Singapore; Bayer Pharma, Austria; Bayer Pharma AG, Norway; Bayer Santé, France; Bayer Schering, Czech Republic; Bayer Schering, Poland; Bayer-Schering, Romania; Bayer Vital, Germany


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.